CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eblen, S. T.
Right arrow Articles by Leof, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eblen, S. T.
Right arrow Articles by Leof, E. B.

Cell Growth & Differentiation, Vol 6, Issue 8 915-925, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1

ST Eblen, MP Fautsch, RA Anders and EB Leof
Department of Cell Biology, Vanderbilt University, Nashville, Tennessee, USA.

Mammalian cultures primarily regulate cell cycle traverse during G1. For progression through G1 and commitment to DNA synthesis, the activity of a family of proteins, the cyclin-dependent kinases (cdks), is required. There are two primary regulatory portions of G1: (a) the G0-G1 transition, which allows entry into G1; and (b) the G1-S transition, promoting entry to DNA synthesis and commitment to cell division. In the present manuscript, we provide evidence for cross-talk between these two cell cycle transitions. Extracts prepared from quiescent mouse mammary epithelial cells are shown to act in a dominant manner to specifically inhibit the histone H1 kinase activity of preformed/active cdk2, cdk4, cyclin A, or cyclin E complexes from G1-S cell extracts. The inhibitory activity arises as cells enter quiescence and decreases once cultures are stimulated to begin G1 traverse and endogenous cdk activity becomes evident. This activity is associated with the regulated binding of the cdk inhibitor p27Kip1 to cyclin A/cdk2 kinase complexes upon mixing of the extracts. Removal of p27Kip1 from the quiescent cell extract specifically abolishes the inhibitory effect. The inhibitory activity and p27Kip1 binding in vitro depend on incubation of the extracts at physiological temperature or the presence of a reducing agent. The results suggest an interplay between the acquisition of quiescence, cdk activity, and G1 traverse.


This article has been cited by other articles:


Home page
ScienceHome page
A. Kanakkanthara, K. B. Jeganathan, J. F. Limzerwala, D. J. Baker, M. Hamada, H.-J. Nam, W. H. van Deursen, N. Hamada, R. M. Naylor, N. A. Becker, et al.
Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation
Science, September 30, 2016; 353(6307): 1549 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Ma, C. A. Kurtyka, S. Boyapalle, S.-S. Sung, H. Lawrence, W. Guida, and W. D. Cress
A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model
Cancer Res., August 1, 2008; 68(15): 6292 - 6299.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. He and W. D. Cress
E2F-3B Is a Physiological Target of Cyclin A
J. Biol. Chem., June 28, 2002; 277(26): 23493 - 23499.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.